Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × alfatide II × Clear all

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 343 Carboplatin 290 pembrolizumab 273 Gemcitabine 272 Cisplatin 266 Radiotherapy 257 Paclitaxel 254 Docetaxel 248 Bevacizumab 216 Rituximab 202 Capecitabine 193 Nivolumab 183 Dexamethasone 173 Fluorouracil 171 fludarabine 157 Oxaliplatin 150 Doxorubicin 137 Leucovorin 128 Irinotecan 128 Pemetrexed 123 Etoposide 123 Cytarabine 122 fludarabine phosphate 112 Bortezomib 111 Lenalidomide 108 Cetuximab 107 Filgrastim 106 Erlotinib Hydrochloride 99 Temozolomide 96 Radiosurgery 95

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02582801 2019-09-27

Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

Jinling Hospital, China

Phase 1 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡